1/39
Vocabulary practice flashcards based on Exam 4 pharmacology lecture notes.
Ferrous Sulfate
An iron preparation used to treat iron deficiency, taken orally between meals (with orange juice to increase absorption and via straw if liquid) or via the Z-track method for IM; common adverse effects include dark green or black tarry stools, constipation, heartburn, nausea, and hepatic necrosis.
Deferoxamine
An intravenous reversal agent that binds iron to facilitate excretion through the kidneys in cases of ferrous sulfate overdose.
Epoetin Alfa
An erythropoiesis-stimulating agent administered IV or SubQ primarily to treat anemia associated with end-stage renal disease; carries adverse risks of hypertension, seizures, and increased risk for MI or stroke.
Heparin
An anticoagulant indicated for stroke, PE, massive DVT, and DIC that inhibits specific clotting factors to prevent clot enlargement or formation (without dissolving clots); administered SQ using a 25 to 26-gauge needle without aspiration or massage, or via IV pump.
Protamine Sulfate
The specific reversal antidote administered to treat heparin overdose and bleeding complications.
Enoxaparin (Lovenox)
A low molecular weight heparin used for postoperative DVT prevention, DVT/PE treatment, and acute coronary syndromes; injected SubQ at a 90♮ angle 2 inches from the umbilicus without expelling the air bubble, aspirating, or rubbing the site.
Warfarin
An oral anticoagulant that antagonizes vitamin K to prevent the synthesis of clotting factors VII, IX, X, and prothrombin; takes 3 to 5 days for full therapeutic effect and lasts 5 days post-discontinuation.
Phytonadione (Vitamin K)
The specific reversal antidote for warfarin toxicity, available for oral, IV, SQ, and IM administration; also administered to neonates to prevent intracranial hemorrhage.
Hemophilia A
A genetic bleeding disorder accounting for 80% of hemophilia cases caused by a deficiency in clotting factor VIII, presenting with hemarthrosis, epistaxis, and prolonged bleeding after trauma.
Hemophilia B
A genetic bleeding disorder accounting for 20% of hemophilia cases caused by a deficiency in clotting factor IX; its factor replacement medications are not interchangeable with factor VIII.
Clopidogrel (Plavix)
An oral antiplatelet medication used to reduce thrombotic events; must be discontinued 5 to 7 days prior to elective surgery due to bleeding risks.
Salicylism (Aspirin Toxicity)
Toxicity resulting from aspirin (ASA) overdose characterized by tinnitus, vomiting, dehydration, fever, double vision, and feeling faint.
Colesevelam
A bile acid sequestrant taken orally with food and 8 ounces of water to reduce low-density lipoprotein (LDL) levels; adverse effects include constipation and bloating, and it must be spaced 4 hours apart from other medications.
Rhabdomyolysis
A severe adverse effect associated with statins (such as atorvastatin and simvastatin) characterized by the breakdown of muscle fibers due to trauma or ischemia, which can precipitate renal failure.
Oxybutynin
An antispasmodic indicated for the relief of bladder instability and reflex neurogenic bladder by relaxing smooth muscle; adverse effects include dry mouth, urinary hesitancy, decreased sweating, and angioedema.
Pentosan Polysulfate Sodium
A medication indicated for bladder pain associated with interstitial cystitis that acts by preventing irritating solutes in the urine from contacting the bladder wall mucosal cells.
Finasteride
A 5-alpha reductase inhibitor prescribed to shrink an enlarged prostate in BPH and promote hair regrowth; crushed tablets must not be handled by pregnant females due to potential transdermal absorption and fetal harm.
Doxazosin
An alpha-adrenergic blocker identified as the preferred initial drug for the treatment of benign prostatic hyperplasia (BPH); takes 6 to 12 months for full therapeutic benefit and commonly causes depression.
Phenazopyridine
A urinary tract mucosal analgesic providing rapid symptomatic relief of lower urinary tract burning, pain, and urgency; adverse effects include yellowing of the skin and sclera, reddish-orange urine discoloration, and contact lens staining.
Digoxin
A second-line cardiac glycoside for heart failure and atrial fibrillation with a narrow therapeutic range of 0.8 to 1.8; toxicity presents with yellow-green halos, visual disturbances, bradycardia, confusion, and GI distress.
Digoxin Immune Fab (Digibind)
The specific antibody fragment antidote indicated for the treatment of life-threatening digoxin toxicity.
Niacin
A nicotinic acid agent used to lower VLDL levels; adverse effects include intense cutaneous flushing, hot flashes, hepatotoxicity, and hyperuricemia triggering gout.
Nitroglycerin
A nitrate vasodilator indicated for acute angina and prophylaxis; sublingual forms are taken every 5 minutes up to a maximum of 3 doses, transdermal patches require a 10 to 12 hours/day nitrate-free interval, and concurrent use with PDE-5 inhibitors is contraindicated.
Metoprolol
A selective beta-1 adrenergic blocker used for hypertension and heart failure that decreases conduction through the AV node; withhold and notify the provider if heart rate is <50bpm or systolic blood pressure is <100mmHg.
Adenosine
An antiarrhythmic agent administered as a rapid IV bolus of 6mg over 3 to 5seconds (followed by 12mg if necessary) via an IV line above the antecubital fossa to convert paroxysmal supraventricular tachycardia (PSVT) back to sinus rhythm.
Ivabradine
A medication that slows heart rate to reduce heart failure hospitalization in stable patients; uniquely associated with the adverse effect of luminous phenomena (visual brightness).
Lidocaine
An antiarrhythmic indicated for the management of acute ventricular arrhythmias that acts by decreasing myocardial depolarization and elevating the ventricular fibrillation threshold.
Acetazolamide
A carbonic anhydrase inhibitor used as adjunct therapy for open-angle glaucoma, drug-induced edema, and acute mountain sickness; adverse effects include metabolic acidosis, bone marrow suppression, and renal calculi.
Mannitol
An osmotic diuretic that draws water into the renal tubules without sodium loss; indicated in acute situations to reduce elevated intracranial pressure or manage acute renal failure caused by shock or trauma.
Furosemide
A loop diuretic identified as the drug of choice for rapid diuresis in heart failure and pulmonary edema; carries a black box warning for profound diuresis leading to hypokalemia, hypocalcemia, and electrolyte depletion.
Hydrochlorothiazide
A thiazide diuretic that inhibits sodium absorption in the distal renal tubule to increase water excretion; adverse effects include electrolyte imbalances, dysrhythmias, and gout.
Spironolactone
A potassium-sparing diuretic that blocks aldosterone to treat hypertension and edema; carries a risk of hyperkalemia and endocrine side effects including gynecomastia and hirsutism.
Amiodarone
An antiarrhythmic that acts directly on cardiac tissue to treat life-threatening ventricular arrhythmias; adverse effects include blue-gray skin discoloration, phototoxicity, and corneal microdeposits.
Ranolazine
A first-line medication for chronic angina that also lowers blood glucose; contraindicated in patients with existing prolonged QT intervals or hepatic impairment.
Lisinopril
An ACE inhibitor used for hypertension, heart failure, and post-MI management within 24hours; carries a black box warning for fetal injury/death and causes hyperkalemia and angioedema.
Losartan
An angiotensin II receptor blocker (ARB) indicated for hypertension and heart failure in patients >6years old; adverse effects include hyperkalemia, azotemia, oliguria, and renal failure.
Verapamil
A calcium channel blocker indicated for hypertension, angina, and dysrhythmias; adverse effects include bradycardia, hypotension, and severe constipation, which requires dietary fiber supplementation.
Propranolol
A non-selective beta-adrenergic blocker that decreases heart rate and blood pressure; patients must be educated never to discontinue the medication abruptly and to notify their provider if heart rate falls below 60bpm.
Left-Sided Heart Failure
A condition where blood accumulates in the left ventricle causing hypertrophy and backing up into the pulmonary vasculature, manifesting with cough, shortness of breath, dyspnea, and confusion.
Right-Sided Heart Failure
A condition characterized by backward blood flow into systemic veins, clinically presenting with peripheral edema, liver engorgement, jugular venous distention (JVD), and weight gain.